category,datetime,headline,id,image,related,source,summary,url
company,1768472026,Biogen: Why I Anticipate A Difficult 2026 For 'End Of An Era' Pharma,138121264,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2159351618/image_2159351618.jpg?io=getty-c-w1536,BIIB,SeekingAlpha,"Biogen faces revenue headwinds, MS franchise erosion, underperforming launches, weak pipeline, and cost-cutting focus. Learn why BIIB stock is upgraded to sell.",https://finnhub.io/api/news?id=1c24417d4417286090801d483a684016a6f0f0707077f7e148a068633d184fcd
